China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients

Stroke Clinical Trial

— CRIST  

Official title:

China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02156765
• Other study ID #: TTYY-20140410
• Status: Recruiting
• Phase: N/A
• First received: June 3, 2014
• Last updated: June 4, 2014
• Start date: October 2013
• Est. completion date: March 2015

Study information

• Verified date: June 2014
• Source: Ministry of Science and Technology of the People´s Republic of China
• Contact: yongjun wang, doctor
• Phone: 13911172565
• Email: yongjunwang1962[@]gmail.com
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Three purpose of this study:

1. Increase diagnosis rate and formulate the flow of diagnosis and treatment of AF in ischemic stroke patients;

2. Evaluation on specificity and sensitivity of STAF score;

3. Analyze the pathogenesis of ischemic stroke and risk factors and establish clinical database and sample database of ischemic stroke.

Description:

Inclusion criteria:

1. Hospitalized patients with ischemic stroke that are diagnosed definitely;

2. Age ≥ 18 years;

3. Within 7 days after the onset of diseases;

4. Signed the consent informed form.

Exclusion criteria:

1. Patients with noncerebrovascular diseases that are diagnosed definitely;

2. Silent cerebral infarction (CI) without symptoms and signs;

3. Those refuse to sign the consent informed form of the study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 3000
• Est. completion date: March 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Hospitalized patients with ischemic stroke that are diagnosed definitely;

2. Age = 18 years;

3. Within 7 days after the onset of diseases;

4. Signed the consent informed form.

Exclusion Criteria:

1. Patients with noncerebrovascular diseases that are diagnosed definitely;

2. Silent cerebral infarction (CI) without symptoms and signs;

3. Those refuse to sign the consent informed form of the study.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Atrial Fibrillation
• Stroke

Locations

Country	Name	City	State
China	Beijing Stroke Association	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
yongjun wang

Country where clinical trial is conducted

China, 

References & Publications (1)

Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005 Nov;58(5):688-97. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Accumulated detection rate of AF	ECG was monitored for all patients enrolled in a single center for consecutive 6 days	1.5 year	No